MicroRNAs and cancer-new paradigms in molecular oncology

Massimo Negrini, Milena S. Nicoloso, George A. Calin

Research output: Contribution to journalArticlepeer-review


The 'classic' view of molecular oncology indicates that cancer is a genetic disease involving tumor suppressor and oncogenic proteins. However, in the recent years, it has been demonstrated that small regulatory non-coding RNAs (ncRNAs) named microRNAs (miRNAs) are involved in human tumorigenesis, thus revealing a new layer in the molecular architecture of human cancer. Gene expression studies revealed that hundreds of miRNAs are deregulated in cancer cells and functional studies clarified that miRNAs are involved in all the molecular and biological processes that drive tumorigenesis. Here, we summarize the recent advances in miRNA involvement in human cancer and illustrate the benefits of using these knowledge for medical practice. New diagnostic classifiers based on miRNAs will soon be available for medical practitioners and, even more importantly, miRNAs may become novel anti-cancer tools.

Original languageEnglish
Pages (from-to)470-479
Number of pages10
JournalCurrent Opinion in Cell Biology
Issue number3
Publication statusPublished - Jun 2009

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'MicroRNAs and cancer-new paradigms in molecular oncology'. Together they form a unique fingerprint.

Cite this